Harsha Koneru

MedStar Georgetown University Hospital

Papers

1

Total Citations

24

H-Index

1

About

Harsha Koneru is a leading figure in the field of radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for prostate cancer. His research centers on mitigating the acute urinary morbidity associated with high-dose, large-fraction radiation treatments. Koneru’s major contribution lies in pioneering strategies to protect the prostatic urethra during SBRT, demonstrating that prophylactic alpha-adrenergic antagonists combined with precise urethral dose reduction can significantly lower toxicity rates. His seminal 2016 paper on this topic, with 24 citations, established a critical framework for improving patient quality of life during treatment. By systematically addressing the unavoidable irradiation of the prostatic urethra, Koneru’s work has directly influenced clinical protocols, enabling safer delivery of ablative radiation doses. His research is highly regarded for translating dosimetric planning into tangible patient benefits, reducing the incidence of severe urinary side effects. Koneru’s contributions are essential reading for oncologists and medical physicists seeking to optimize SBRT, balancing tumor control with functional preservation. His work continues to shape evidence-based practices in prostate cancer radiotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction
24 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: MedStar Georgetown University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago